Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Medtronic PLC (MDT : NYSE)
 
 • Company Description   
Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions.

Number of Employees: 95,000

 
 • Price / Volume Information   
Yesterday's Closing Price: $86.02 Daily Weekly Monthly
20 Day Moving Average: 8,161,050 shares
Shares Outstanding: 1,282.54 (millions)
Market Capitalization: $110,324.38 (millions)
Beta: 0.79
52 Week High: $96.25
52 Week Low: $75.96
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 3.66% -0.73%
12 Week 3.79% -14.69%
Year To Date 7.69% 2.60%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
BUILDING TWO PARKMORE BUSINESS PARK WEST
-
GALWAY,L2 H91
IRL		 ph: 353-1438-1700
fax: 763-514-4879		 investor.relations@medtronic.com http://www.medtronic.com
 
 • General Corporate Information   
Officers
Geoffrey S. Martha - Chairman and Chief Executive Officer
Thierry Pieton - Executive Vice President and Chief Financial Offic
Matthew Walter - Senior Vice President
Ivan K. Fong - Executive Vice President; General Counsel and Secr
Denise L. Blomquist - Vice President; Global Controller and Chief Accoun

Peer Information
Medtronic PLC (BJCT)
Medtronic PLC (CADMQ)
Medtronic PLC (APNO)
Medtronic PLC (UPDC)
Medtronic PLC (IMTIQ)
Medtronic PLC (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: G5960L103
SIC: 3845
Fiscal Year
Fiscal Year End: April
Last Reported Quarter: 04/01/25
Next Expected EPS Date: 08/19/25
Share - Related Items
Shares Outstanding: 1,282.54
Most Recent Split Date: 9.00 (2.00:1)
Beta: 0.79
Market Capitalization: $110,324.38 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 3.30%
Current Fiscal Quarter EPS Consensus Estimate: $1.23 Indicated Annual Dividend: $2.84
Current Fiscal Year EPS Consensus Estimate: $5.55 Payout Ratio: 0.51
Number of Estimates in the Fiscal Year Consensus: 14.00 Change In Payout Ratio: -0.01
Estmated Long-Term EPS Growth Rate: 6.68% Last Dividend Paid: 06/26/2025 - $0.71
Next EPS Report Date: 08/19/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 15.51
Trailing 12 Months: 15.64
PEG Ratio: 2.32
Price Ratios
Price/Book: 2.29
Price/Cash Flow: 11.10
Price / Sales: 3.29
EPS Growth
vs. Year Ago Period: 10.96%
vs. Previous Quarter: 16.55%
Sales Growth
vs. Year Ago Period: 3.94%
vs. Previous Quarter: 7.66%
ROE
04/30/25 - 14.54
01/31/25 - 14.07
10/31/24 - 13.79
ROA
04/30/25 - 7.83
01/31/25 - 7.70
10/31/24 - 7.62
Current Ratio
04/30/25 - 1.85
01/31/25 - 1.90
10/31/24 - 1.84
Quick Ratio
04/30/25 - 1.42
01/31/25 - 1.43
10/31/24 - 1.39
Operating Margin
04/30/25 - 21.11
01/31/25 - 20.87
10/31/24 - 20.82
Net Margin
04/30/25 - 13.90
01/31/25 - 12.83
10/31/24 - 13.00
Pre-Tax Margin
04/30/25 - 16.78
01/31/25 - 15.73
10/31/24 - 15.62
Book Value
04/30/25 - 37.62
01/31/25 - 38.69
10/31/24 - 37.99
Inventory Turnover
04/30/25 - 2.12
01/31/25 - 2.12
10/31/24 - 2.11
Debt-to-Equity
04/30/25 - 0.53
01/31/25 - 0.48
10/31/24 - 0.51
Debt-to-Capital
04/30/25 - 34.70
01/31/25 - 32.59
10/31/24 - 33.56
 

Powered by Zacks Investment Research ©